Koers Cell MedX Corp. Other OTC
Aandelen
CMXC
US15115X1072
Biotechnologie & Medisch Onderzoek
Omzet 2022 | 0,01 0,01 | Omzet 2023 | 0 0 | Marktkapitalisatie | 6,29K 5,86K |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | - 0 | Nettowinst (verlies) 2023 | - 0 | EV/omzet 2022 | 1.135.153.669 x |
Nettoschuld 2022 | 592K 552K | Nettoschuld 2023 | 903K 840K | EV/omzet 2023 | 329.116.944 x |
K/w-verhouding 2022 |
-9,01
x | K/w-verhouding 2023 |
-0,01
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 20,34% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
David Jeffs
CEO | Chief Executive Officer | 54 | 12/12 |
Yanika Silina
DFI | Director of Finance/CFO | 45 | 24-11-14 |
George Adams
CHM | Chairman | 76 | 23-03-18 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David Jeffs
CEO | Chief Executive Officer | 54 | 12/12 |
Dwayne Yaretz
BRD | Director/Board Member | 63 | 27-04-22 |
Joao da Costa
BRD | Director/Board Member | 59 | 08-06-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+26,28% | 48,09 mld. | |
-3,99% | 40,43 mld. | |
+46,85% | 40,62 mld. | |
-6,20% | 28,36 mld. | |
+6,36% | 24,89 mld. | |
-21,47% | 19,01 mld. | |
+27,58% | 12,09 mld. | |
-2,75% | 11,8 mld. | |
-2,02% | 11,88 mld. |